About US
Contact us
-
Trump's latest pharma-fighting plan? Use Twitter to force prices down, manufacturing to U.S.Pharma is fast becoming President-elect Donald Trump’s favorite whipping boy. Last month, Trump vowed tobring downdrug prices. Last week, heslammedthe industry for “getting away with murder.” And Satu2017/2/4
-
Surprise Keytruda-chemo FDA filing puts Merck ahead in I-O combo raceMerck & Co.’s immunotherapy drug Keytruda is yet another step closer to eclipsing its competitors in lung cancer. In an out-of-the-blue announcement late Tuesday, the U.S.-based drugmaker said the2017/2/3
-
Sanofi's Brandicourt announces at JPM that plant issues leading to CRL for RA drug have been fixedSanofi CEO Olivier Brandicourt believes the French drugmaker has fixed the issues at a fill/finish plant in France that led it and partner Regeneron to get a complete response letter for experimental2017/2/3
-
EU regulators come down on repackager they say faked dataEuropean regulators have come down on a Danish pharma repackager that they say tried to hide violations from inspectors. According to areporton the European Medicines website, the Danish Medicines Ag2017/1/25
-
J&J and Actelion reportedly take complicated deal to Swiss regulator for rulingThere is evidence that Actelion and Johnson & Johnson are edging closerto a deal to give the U.S. drugmaker control of the Swiss biotech, sort of. Citing a report in the Swiss newspaper Tages-Anz2017/1/25
-
Applying Digital Technologies to Profit from Change in the Pharma IndustryPharmaceutical companies are increasingly challenged to keep pace with the evolving demands of patients, physicians and payors. In particular, patients’ desires to be more involved in their treatments2017/1/24
-
With backing from cancer bigwigs, VP Biden reportedly eyes drug prices as part of new nonprofit workAfter finishing eight years as vice president and a stint as Cancer Moonshotguru, Joe Biden plans to head up a new nonprofit to work on cancer issues—and tackling high drug prices is one of them. Bid2017/1/24
-
Greek prosecutors raid Novartis offices, disclose wide-ranging probe into bribery allegationsGreek officialsannouncedTuesday that they are investigating Novartis for bribery in the wake of local media reports raising questions about the company. It is the fourth set of bribery allegations aga2017/1/23
-
The FDA's promo police slap four more pharmas in year-end enforcement spreeThe FDA’s promotional enforcement squad wasn’t very active in 2016—until December, that is. Since the beginning of the month, the Office of Prescription Drug Promotion has cited six drugmakers for ove2017/1/22
-
It's the same song, but a brand-new verse for 2017's drug-pricing debateWe won’t surprise anyone by saying that Topic No. 1 in pharma this year was drug pricing. We’ll give you one guess as to whether 2017 will be more of the same. The advent of a Trump Administration es2017/1/20